Top Buy
| Security | Buy | Sell | Buy (1M) ▲ | Sell (1M) | Price | Target price | Potential |
|---|---|---|---|---|---|---|---|
| MorphoSys AG | 7 | 0 | 0 | 0 | €69.45 | €65.00 | -6.407% |
| QIAGEN NV | 9 | 0 | 0 | 0 | €40.47 | €47.44 | 17.223% |
| Viatris Inc. | 1 | 0 | 0 | 0 | €10.10 | - | - |
| Perrigo Co. plc | 3 | 0 | 0 | 0 | €27.44 | €35.99 | 31.142% |
| Nektar Therapeutics | 3 | 1 | 0 | 0 | €1.62 | €3.70 | 129.102% |
| Horizon Pharma plc | 6 | 0 | 0 | 0 | €110.40 | - | - |
| Ascendis Ph.sp.adr 1 Dk 1 | 1 | 0 | 0 | 0 | €114.00 | €150.00 | 31.579% |
| Novocure Ltd | 1 | 1 | 0 | 0 | €20.24 | - | - |
| Hutchison China MediTech Ltd ADR | 5 | 0 | 0 | 0 | €18.60 | €45.10 | 142.446% |
| Canopy Growth Corp | 4 | 0 | 0 | 0 | €0.47 | €1.75 | 273.134% |
| Blueprint Medicines Corp | 2 | 0 | 1 | 0 | €96.50 | - | - |
| PTC Therapeutics Inc. | 13 | 5 | 1 | 0 | €30.00 | €41.81 | 39.380% |
| Repligen Corp. | 13 | 0 | 1 | 0 | €158.05 | €184.76 | 16.900% |
| Uniqure B.V. | 1 | 0 | 1 | 0 | €4.61 | - | - |
| Xencor Inc. | 10 | 1 | 1 | 0 | €22.60 | €32.58 | 44.154% |
| Arrowhead Pharmaceuticals Inc. | 14 | 2 | 2 | 0 | €23.02 | €52.03 | 125.999% |
| Halozyme Therapeutics Inc. | 14 | 0 | 2 | 0 | €41.14 | €50.33 | 22.345% |
| Agios Pharmaceuticals Inc. | 6 | 0 | 2 | 0 | €31.80 | €38.99 | 22.606% |
| Alnylam Pharmace. | 36 | 0 | 2 | 0 | €137.45 | €236.30 | 71.916% |
| Ultragenyx Pharmaceutical Inc. | 17 | 1 | 3 | 0 | €39.20 | €84.74 | 116.184% |
| Jazz Pharmaceuticals plc | 23 | 0 | 3 | 0 | €100.25 | €184.92 | 84.459% |
| Medpace Holdings Inc | 9 | 0 | 3 | 0 | €361.50 | €421.61 | 16.627% |